114 related articles for article (PubMed ID: 2895114)
1. Analysis of drugs from biological fluids using disposable solid phase columns.
Doyle E; Pearce JC; Picot VS; Lee RM
J Chromatogr; 1987 Dec; 411():325-33. PubMed ID: 2895114
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic separation of cadralazine from its potential metabolites and degradation products. Quantitation of the drug in human plasma and urine.
Crolla T; Santini F; Visconti M; Pifferi G
J Chromatogr; 1984 Sep; 310(1):139-49. PubMed ID: 6501510
[TBL] [Abstract][Full Text] [Related]
3. Measurement of concentrations of the histamine H1 receptor antagonist temelastine in biological fluids.
Rogers SJ; Doyle E; McCulla BA; Lee RM
J Pharm Sci; 1986 Aug; 75(8):813-4. PubMed ID: 2877079
[TBL] [Abstract][Full Text] [Related]
4. High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine.
Randolph WC; Osborne VL; Walkenstein SS; Intoccia AP
J Pharm Sci; 1977 Aug; 66(8):1148-50. PubMed ID: 19614
[TBL] [Abstract][Full Text] [Related]
5. The assay of a novel histamine H2-receptor antagonist, SK&F 93479, in human plasma by normal-phase high-performance liquid chromatography.
McDowall RD; Lee RM
J Chromatogr; 1983 Jul; 275(2):377-85. PubMed ID: 6137490
[TBL] [Abstract][Full Text] [Related]
6. High throughput liquid chromatography/mass spectrometry bioanalysis using 96-well disk solid phase extraction plate for the sample preparation.
Simpson H; Berthemy A; Buhrman D; Burton R; Newton J; Kealy M; Wells D; Wu D
Rapid Commun Mass Spectrom; 1998; 12(2):75-82. PubMed ID: 9470219
[TBL] [Abstract][Full Text] [Related]
7. Automated on-line renewable solid-phase extraction-liquid chromatography exploiting multisyringe flow injection-bead injection lab-on-valve analysis.
Quintana JB; Miró M; Estela JM; Cerdà V
Anal Chem; 2006 Apr; 78(8):2832-40. PubMed ID: 16615800
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic assay for nizatidine, a new H2 blocker, in human plasma and urine using disposable solid-phase extraction columns.
Carlucci G
J Chromatogr; 1990 Feb; 525(2):490-4. PubMed ID: 1970345
[No Abstract] [Full Text] [Related]
9. Evaluation of column extraction: a new procedure for the analysis of drugs in body fluids.
Breiter J; Helger R; Lang H
Forensic Sci; 1976; 7(2):131-40. PubMed ID: 964805
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in microextraction by packed sorbent for bioanalysis.
Abdel-Rehim M
J Chromatogr A; 2010 Apr; 1217(16):2569-80. PubMed ID: 19811788
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatography/tandem mass spectrometric bioanalysis using normal-phase columns with aqueous/organic mobile phases - a novel approach of eliminating evaporation and reconstitution steps in 96-well SPE.
Naidong W; Shou WZ; Addison T; Maleki S; Jiang X
Rapid Commun Mass Spectrom; 2002; 16(20):1965-75. PubMed ID: 12362389
[TBL] [Abstract][Full Text] [Related]
12. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
Xue YJ; Akinsanya JB; Liu J; Unger SE
Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatographic determination of 9-methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one in human plasma with fluorescence detection.
Cheng H; Pittman KA; Dandekar KA
J Pharm Sci; 1987 Dec; 76(12):918-9. PubMed ID: 2894450
[TBL] [Abstract][Full Text] [Related]
14. Automated sample preparation techniques for the determination of drug enantiomers in biological fluids using liquid chromatography with chiral stationary phases.
Ceccato A; Toussaint B; Chiap P; Hubert P; Crommen J
Enantiomer; 1999; 4(3-4):305-15. PubMed ID: 10550889
[TBL] [Abstract][Full Text] [Related]
15. Dendrimer-functionalized mesoporous silica as a reversed-phase/anion-exchange mixed-mode sorbent for solid phase extraction of acid drugs in human urine.
Li Y; Yang J; Huang C; Wang L; Wang J; Chen J
J Chromatogr A; 2015 May; 1392():28-36. PubMed ID: 25795396
[TBL] [Abstract][Full Text] [Related]
16. Sample preparation for the HPLC analysis of drugs in biological fluids.
McDowall RD; Doyle E; Murkitt GS; Picot VS
J Pharm Biomed Anal; 1989; 7(9):1087-96. PubMed ID: 2490115
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a new H2 receptor antagonist, 3-amino-5-[3-[4-(1-piperidinoindanyloxy)]propylamino]-1-methyl-1 H-1,2,4-triazole, in human plasma and urine by high-performance liquid chromatography.
Miksic JR; Rivel ER; Rush K
J Chromatogr; 1988 Jun; 428(1):113-21. PubMed ID: 2902101
[TBL] [Abstract][Full Text] [Related]
18. XAD-2 resin drug extraction methods for biologic samples.
Stolman A; Pranitis PA
Clin Toxicol; 1977; 10(1):49-60. PubMed ID: 858225
[TBL] [Abstract][Full Text] [Related]
19. Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine.
Vincek WC; Constanzer ML; Hessey GA; Bayne WF
J Chromatogr; 1985 Mar; 338(2):438-43. PubMed ID: 2860117
[No Abstract] [Full Text] [Related]
20. Rapid screening for 100 basic drugs and metabolites in urine using cation exchange solid-phase extraction and high-performance liquid chromatography with diode array detection.
Logan BK; Stafford DT; Tebbett IR; Moore CM
J Anal Toxicol; 1990; 14(3):154-9. PubMed ID: 2374404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]